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a b s t r a c t
The small hydrophobic (SH) protein is a short channel-forming polypeptide encoded by the human
respiratory syncytial virus (hRSV). Deletion of SH protein leads to the viral attenuation in mice and
primates, and delayed apoptosis in infected cells. We have used a membrane-based yeast two-hybrid
system (MbY2H) and a library from human lung cDNA to detect proteins that bind SH protein. This led to
the identiﬁcation of a membrane protein, B-cell associated protein 31 (BAP31). Transfected SH protein
co-localizes with transfected BAP31 in cells, and pulls down endogenous BAP31. Titration of puriﬁed
C-terminal endodomain of BAP31 against isotopically labeled SH protein in detergent micelles suggests
direct interaction between the two proteins. Given the key role of BAP31 in protein trafﬁcking and its
critical involvement in pro- and anti-apoptotic pathways, this novel interaction may constitute a
potential drug target.
& 2015 Elsevier Inc. All rights reserved.
Introduction
The human respiratory syncytial virus (hRSV) is an enveloped
pneumovirus in the paramyxoviridae family that causes lower
respiratory tract disease in infants, elderly and immunocompro-
mised populations worldwide (Dowell et al., 1996). Up to 64
million reported cases of hRSV infection and 160,000 deaths occur
each year. Although the virus was identiﬁed almost half a century
ago (Blount et al., 1956), there are still no vaccines or effective
antiviral drugs available. hRSV can cause repeated reinfections
throughout life, and its molecular mechanism of pathogenesis is
not yet completely understood.
The hRSV genome comprises a nonsegmented negative-stranded
RNA of15 kb that transcribes 11 proteins, including the three
membrane proteins F, G, and small hydrophobic (SH). Proteins F
and G are key factors during virus attachment, fusion and entry into
host cells (Krusat and Streckert, 1997; Lamb, 1993). The role of SH
protein is less clear; RSV lacking the SH gene (RSVΔSH) caused
formation of syncytia, and grew as well as the wild-type (WT) virus
in cells, but it replicated 10-fold less efﬁciently than the WT in the
upper respiratory tract, and was attenuated in vivo (Bukreyev et al.,
1997; Fuentes et al., 2007; Jin et al., 2000; Karron et al., 1997;
Whitehead et al., 1999). Overall, these results indicate involvement of
SH protein in the pathogenesis of RSV infection.
Homologs of RSV SH protein are found in parainﬂuenza virus 5
(PIV5), mumps virus (MuV), and J paramyxovirus (JPV). In all these
systems, SH protein seems to block or delay apoptosis in infected
cells through inhibition of the TNF-α pathway (Fuentes et al., 2007; Li
et al., 2011; Lin et al., 2003; Wilson et al., 2006a), although this may
not be the only mechanism involved. It is thought that by delaying
apoptosis the virus may evade host inﬂammatory responses and the
premature death of the host cells.
The SH protein is a 64 (RSV subgroup A) or 65 (RSV subgroup B)
amino acids long type II integral membrane protein, with C- and
N-termini oriented lumenally/extracellularly and cytoplasmically,
respectively. In infected cells, most SH protein accumulates at the
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membranes of the Golgi complex, but it has also been detected in
the endoplasmic reticulum and plasma membranes (Rixon et al.,
2004). During infection, the full-length unmodiﬁed form is the
major species (Collins and Mottet, 1993), although a truncated
form (4.5 kDa) and glycosylated and phosphorylated forms have
also been detected (Olmsted and Collins, 1989; Rixon et al., 2005).
SH protein has a single predicted α-helical transmembrane (TM)
domain (Collins and Mottet, 1993) which is highly conserved
(Chen et al., 2000; Collins et al., 1990).
A pentameric oligomer is responsible for channel activity in planar
lipid bilayers (Gan et al., 2008; Gan et al., 2012). The correct orientation
of the TM monomers in the lipid bilayer was determined using site
speciﬁc infrared dichroism (Gan et al., 2008) and NMR studies in
dodecylphosphocholine (DPC) micelles (Gan et al., 2012). In the latter
system, the single α-helical TM domain is ﬂanked N-terminally by an
α-helix (cytoplasmic), and C-terminally (lumenal) by an extended
β-hairpin. Later reﬁnement of this structure in bicelles, a closer
membrane-mimic system, conﬁrmed the presence of a cytoplasmic
N-terminal helix, but the TM domain extended its helix in the lumenal
domain until His-51 (Li et al., 2014). In the latter paper, channel activity
measurements in black lipid membranes of puriﬁed SH protein
demonstrated low or no ion selectivity and amild inhibition at low pH.
Since the structure of SH protein in micelles and in bicelles has
been determined reliably, a search for protein binding partners
was performed with the membrane-based yeast two-hybrid sys-
tem, which is especially suitable for membrane proteins (Huang
et al., 2005; Lentze and Auerbach, 2008; Wang et al., 2004). The
system uses split-ubiquitin, where reassembly of N- and C-termini
(Nub and Cub) leads to proteolytic cleavage, and release of
transcription factor triggers the activation of a reporter system
(Thaminy et al., 2004). An artiﬁcial transcription factor consisting
of bacterial LexA protein and the Herpes simplex VP16 transacti-
vator protein is fused to the Cub moiety (Cub-LexA-VP16 reporter
cassette). As SH protein is type II, its N-terminal extramembrane
α-helix should be in the cytosol.
The interaction with an important membrane protein, BAP31,
was conﬁrmed by co-localization and pull-down studies with both
transfected and endogenous BAP31. In addition, the cytoplasmic
domain of BAP31 was expressed and puriﬁed, and its interaction
with SH protein in the presence of detergent was characterized
using isotopically labeled SH protein. Future work in RSV infected
cells should determine the importance and effect of this interac-
tion, and characterization of the protein-protein interaction has to
be made using labeled BAP31 endodomain.
Fig. 1. EGFP-SH protein co-localization with BAP31-RFP in C2C12 and human lung carcinoma A549 cells. (A) C2C12 myoblast cells transfected with plasmids pBAP31-RFP and
either pEGFP (negative control) or pEGFP-SH; co-localization was detected with ﬂuorescence microscopy; DIC, differential interference contrast microscopy; (B) human lung
carcinoma A549 cells transfected with pEGFP-SH with pRFP (negative control) or pBAP31-RFP. EGFP-SH was found to be co-localized with BAP31-RFP.
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Results
BAP31 was identiﬁed as a novel target for RSV SH protein using a
yeast two-hybrid screen
To identify potential interacting partners of RSV SH protein, we
performed a yeast two-hybrid analysis which can detect interactions
involving both cytoplasmic and transmembrane domains. Initially,
full length SH protein was expressed in plasmid pBT3-SH, i.e., as a
fusion to the C-terminal half of ubiquitin (Cub) linked to the
transcription factor LexA-VP16. However, when this plasmid was
co-transformed with pOst1-NubI (wild-type N-terminal semi-ubiqui-
tin) or with pPR3-N (mutant), cells grew only in SD-LT non-selective
plate, indicating lack of SH protein expression in this system (not
shown). Therefore, following experiments used a truncated form of
SH protein, SHTR, spanning the transmembrane domain and an intact
cytoplasmic domain (residues M1-L44).
From a blast result (BLASTX), 16 proteins were identiﬁed.
However, only six genes were expressed in-frame with the NubG
moiety: ribosomal proteins L3, L7, S13, P450 cytochrome oxido-
reductase, transaldolase 1, and only one membrane protein, B-cell
receptor-associated protein 31 (BAP31). BAP31 is the most abundant
membrane protein in the ER, and has three predicted TM domains
and a large cytoplasmic C-terminal domain (endodomain). Because
of BAP31 role in sorting of membrane proteins and in caspase-8
mediated apoptosis, we focused our efforts in conﬁrming BAP31-SH
interaction in the cellular environment.
BAP31 and SH protein co-localization in C2C12 and human lung
carcinoma A549 cells
We next investigated the co-localization of SH protein and
BAP31 when both proteins were transfected. It is known that
BAP31 and SH protein localize to the ER and Golgi, respectively.
However, SH protein can also be found in the ER (see above). Mouse
myoblast C2C12 cells were transiently transfected with a vector
expressing EGFP-tagged SH protein at the N-terminus (EGFP-SH),
together with BAP31 tagged with RFP at the C-terminus (BAP31-
RFP). The cells were analyzed by ﬂuorescence microscopy 36 h after
transfection, and showed that both BAP31 and SH protein con-
structs co-localize in a perinuclear pattern consistent with the ER
(Fig. 1A). Since RSV is a human respiratory pathogen, we further
analyzed the localization pattern of BAP31 and SH protein in lung
epithelial carcinoma A549 cells. Consistent with the result obtained
in C2C12 cells, BAP31 and SH proteins were found to be co-localized
in A549 cells as well (Fig. 1B).
Pull-down of BAP31 and SH protein
Since SH protein and BAP31 were co-localized, it was important
to determine if they were associated in complexes. For these
studies, a series of immunoprecipitation experiments were per-
formed using HEK293T cells transiently transfected with expres-
sion vectors for EGFP-SH protein or EGFP alone, together with
BAP31-His construct (cloned in pFIV-copGFP vector; System Bios-
ciences). The cell lysate was prepared 36 h after transfection, and
incubated with Ni-NTA Agarose beads to trap BAP31 and its
binding partners. The beads were washed with lysis buffer, and
boiled in SDS-PAGE loading buffer, resolved in SDS-PAGE, and
immuno-blotted with either anti-His or anti-GFP, to detect BAP31
or GFP/EGFP-SH, respectively. Western blot analysis showed that
BAP31-His (detected with anti-His antibody), EGFP-SH and EGFP
(detected with anti-GFP antibody) expressed well in the cells
(Fig. 2A, lysate). However, EGFP-SH protein, but not EGFP alone,
was pulled downwith BAP31-His (Fig. 2A, bound) indicating direct
or indirect complex formation between SH and BAP31 proteins in
the cell.
In order to conﬁrm the interaction between BAP31 and SH
protein, a similar immuno-precipitation experiment was per-
formed to trap endogenously expressed BAP31 (detected by anti-
BAP31 antibody) using GFP-TRAP, which binds EGFP and EGFP-SH
proteins expressed in HEK293T cells. While endogenous BAP31,
EGFP and EGFP-SH were expressed (Fig. 2B, lysate), BAP31 was
only present in the bound fraction in cells expressing EGFP-SH, but
not when cells expressed EGFP alone (Fig. 2B, bound).
Binding site of BAP31 on SH protein
Since the SH protein construct used in the split ubiquitin experi-
ment was truncated and only included the TM domain and the
cytoplasmic domain, it is likely that interaction with BAP31 occurs in
at least one of these two regions. To test if the interaction is direct,
we attempted to conﬁrm interaction at the extramembrane cyto-
plasmic domains between BAP31 and SH protein. Thus, we used
puriﬁed full length SH protein and the endodomain (cytoplasmic) of
BAP31 in solution NMR experiments. 15N-labeled SH protein in DPC
detergent micelles was titrated with increasing proportion of puriﬁed
water soluble non-labeled BAP31 endodomain. Addition of BAP31
endodomain caused a global reduction of signal intensities (Fig. 3A),
suggesting binding to the micelles that incorporate SH protein, with a
corresponding increase in correlation time and band broadening.
Changes were more localized at some residues in the N-terminal
extramembrane domain (Fig. 3B). Some residues in the TM domain
were also affected, although the latter is probably due to allosteric
effects since these residues are protected by the micelle environment
(Gan et al., 2012) and the BAP31 endodomain used is water soluble.
Three residues at the N-terminal helix showed pronounced intensity
reduction, Ile-6, Ile-8, Ser-12 and Trp-15 (Fig. 3B). The fact that the
bands did not shift suggests that the interaction between SH and
BAP31 is probably in the intermediate exchange regime. Not only
these residues are part of a cytoplasmically oriented N-terminal α-
helix, but the residues most affected by this interaction seem to be
located on the same side of the α-helix (Fig. 3C–D)(Gan et al., 2012; Li
et al., 2014). Thus, this N-terminal helix of SH protein constitutes a
likely binding site for BAP31, although it does not exclude that the
TM domains of SH and BAP31 proteins interact. In fact, a SH double
mutant was designed to disrupt that cytoplasmic interaction S12A-
W15A, but both co-localization and pull down results were the same
(not shown), suggesting that the two proteins indeed also interact at
the TM domain.
Discussion
The ER stress response is essential for intracellular homeostatic
balance, and unsettled ER stress can lead to apoptosis. SH protein
in infected cells has been shown previously to have a protective
effect, preventing or delaying apoptosis. The link between SH
protein and apoptosis makes the identiﬁcation of BAP31 as a
binder of SH protein particularly intriguing. Indeed, in addition to
its role in ER protein trafﬁcking, sorting newly synthesized
membrane proteins within the ER (Wang et al., 2008), BAP31
regulates apoptosis through an interaction with Bcl-2 or Bcl-XL
and caspase-8 (Ng et al., 1997; Ng and Shore, 1998). A number of
apoptotic pathways involve the cleavage of the endodomain of
BAP31 by caspase-8 (Breckenridge et al., 2002; Breckenridge et al.,
2003), to produce a p20BAP31 fragment that is a pro-apoptotic
factor (Breckenridge et al., 2003; Rosati et al., 2010).
Cleavage and association to Bcl-2 require the formation of a
complex at the ER membrane with CDIP1, a proapoptotic p53
target, so that apoptotic signals can be transduced from the ER to
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the mitochondria under ER stress (Namba et al., 2013). Further,
crosstalk of apoptosis signals between mitochondria and ER are
enhanced by association between BAP31 and mitochondrial ﬁssion
factor Fis1 (Iwasawa et al., 2011).
In this context, our results suggest a possible link between the
protective effects of RSV SH protein and BAP31, possibly through
sequestering of the BAP31 endodomain by SH protein, thus
preventing cleavage by caspase-8 and delaying apoptosis. It would
be interesting to know if BAP31 interaction is also present for
other SH proteins. Indeed, the cytopathic effect (CPE) produced by
paramyxovirus parainﬂuenza virus 5 PIV5 (He et al., 2001; Lin
et al., 2003; Wilson et al., 2006b), also a member of the Para-
myxoviridae family, was blocked by SH protein or SH protein
homologs from RSV A or B subgroups (Fuentes et al., 2007).
Fig. 2. BAP31 interacts with SH protein. (A) Western blot analysis corresponding to whole lysate (left) and bound fraction (right) after a BAP31-His pull down of EGFP alone
or EGFP-SH. Detection was performed with anti-His antibody against BAP31 (lower panel) or anti-GFP antibody against EGFP-SH (upper panel); (B) Endogenous BAP31 was
pulled down by EGFP-SH using a GFP-TRAP; BAP31 presence was detected using anti-BAP31 antibody.
Fig. 3. Interaction between SH protein and BAP31. (A) Result of the titration of 15N-labeled SH protein by unlabeled BAP31 endodomain at a SH protein/BAP31 molar ratio of
1:1, monitored by [ 1H–15N] –HSQC, with SH protein alone (blue), and after addition of BAP31 endodomain (red). Residues most affected are labeled; (B) Peak intensities
expressed as ratio between peak volume after (V) and before (V0) addition of unlabeled endodomain BAP31 to labeled SH protein. Side (C) and top (D) views of SH protein
pentameric model in micelles (Gan et al., 2012), and BAP31 binding site. Residues that experience extreme line broadening are labeled in red, and their side chains are shown
as line representations. Prolines and overlapping resonances are omitted from the analysis.
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Similarly, SH protein from PIV5 could be substituted by SH protein
from mumps virus (Wilson et al., 2006b). However, these proteins
have no apparent sequence homology, which argues against a
protective mechanism involving speciﬁc protein-protein interac-
tions such as that found with BAP31.
An alternative hypothesis is that the observed interaction may
affect protein sorting or viral egress, and be conﬁned to RSV. We
note that the sequences of RSV SH proteins are particularly well
conserved at the TM and cytoplasmic domain, where we propose
the interaction with BAP31 takes place. Our identiﬁcation of BAP31
using a membrane-associated yeast two hybrid analysis indicates
that SH protein probably binds directly to BAP31, rather than
through intermediary proteins, and this is also indicated by the
NMR data. However, a larger complex of proteins involving SH
protein and BAP31 is still possible. Lastly, it is interesting that
using an identical yeast-based system used herein, the interaction
of BAP31 with high risk human papillomavirus (HPV) 16 and 31 E5
protein was detected (Regan and Laimins, 2008). Like SH protein,
E5 is also a viroporin (Wetherill et al., 2012). The interaction of E5
with BAP31 was proposed to take place through the last E5 C-
terminal amino acids, although this has never been conﬁrmed
using biophysical assays using puriﬁed protein. In that case, it was
proposed that HPV E5 targets BAP31 to support proliferative
competence following differentiation. Although the role of the
interaction between SH and BAP31 proteins is not clear, the results
presented here support a direct interaction that may lead to
sequestering of BAP31 from contacts with other cellular proteins.
These possibilities should be further explored once the relevance
of this interaction to the viral life cycle is studied in more detail.
Materials and methods
Yeast two-hybrid screen
The assay used was a split-ubiquitin based yeast two-hybrid
screen (Dualsystems Biotech, Switzerland) that is an adaptation of
the ubiquitin-based split protein sensor (USPS) (Johnsson and
Varshavsky, 1994). As RSV SH protein is a type II integral protein,
pBT3-N was chosen as bait vector. SH was cloned into Sﬁ I
restriction sites of pBT3-N, so that the cytoplasmic construct
LexA-VP16-Cub was fused to the N-terminus of SH protein. Prey
proteins from Homo sapiens adult total lung RNA (4.8106
independent clones) were used to construct the library in the
pPR3-N vector as a fusion to the N-terminal half of ubiquitin
(NubG). Transformation of the cDNA library was performed
according to the manufacturer's protocol. Upon interaction of a
prey protein with the bait protein, the C- and N-terminal halves of
ubiquitin form a functional enzyme with consequent translocation
of the transcription factor LexA-VP16 into the nucleus. Transcrip-
tion of LexAVP16 was assessed using a quantitative LacZ assay, and
the strongest positive clones were identiﬁed and subsequently
isolated. The sequences were then used for further studies.
Full length SH protein, or a truncated version, SHTR (M1-L44)
were tagged to Cub, whereas the proteins in the library were tagged
to NubG. The human adult lung NubG-x cDNA library was trans-
formed into yeast expressing LexA-VP16-Cub-SH. The transformants
were grown on selective media with 3 mM 3-aminotriazole (3-AT)
in SD-TLH, and 2 mM 3-AT in SD-TLHA. Positive clones were
identiﬁed based on quantitative LacZ assays, and the clones with
the highest expression were isolated. A total of 41 colonies with
robust growth were picked up from the screening media.
BAP31 and SH protein co-localization
Full length SH protein was fused to Enhanced Green Fluores-
cent Protein (EGFP), and BAP31 was fused with Red Fluorescent
Protein (RFP). Both constructs were transfected to mouse myoblast
C2C12 cells and after 36 h post transfection, cells were visualized
using a ﬂuorescence microscope ﬁtted with Photo metrics Cool-
SNAPHQ2 camera. The images were analyzed using Metamorph
software (Molecular devices, CA, USA). In order to conﬁrm the co-
localization of BAP31 with SH protein, similar experiments were
performed with human lung epithelial carcinoma A549 cells.
Pull down experiments of EGFP-SH and co-trasnfected or endogenous
BAP31
HEK293T cells were transfected with a BAP31-His construct
together with (i) EGFP or (ii) EGFP–SH. The lysate was incubated with
Ni-NTA Agarose beads and washed at least three times with lysis
buffer. The beads were boiled in SDS-PAGE loading buffer, resolved
and immuno-blotted with either anti-His or anti-GFP, to detect BAP31
or GFP/EGFP-SH, respectively. Interaction of endogenous BAP31 with
SH protein was performed using GFP-TRAP immuno-precipitation as
suggested (Chromotek). Brieﬂy, HEK293T cells were transfected either
with EGFP or EGFP-SH. 36 h post-transfection, cells were lysed and
GFP-TRAP-IP was performed. Endogenous BAP31 was detected using
anti-BAP31 antibody (Abcam; ab37120).
Protein expression and puriﬁcation of SH protein and BAP31
endodomain
The SH protein used in this work–strain S2 ts1C accession number
NP_044594.1 (Tolley et al., 1996) was cloned, expressed, puriﬁed and
isotopically labeled essentially as described previously (Gan et al.,
2012). The C-terminal cytoplasmic domain (endodomain) of human
BAP31 (UniProt: P51572, residues 124–242) corresponding to two
consecutive coiled-coil forming domains, was cloned, expressed and
puriﬁed as described previously (Quistgaard et al., 2013).
NMR spectroscopy
NMR experiments were performed at 37 1C (310 K) using a
Bruker Avance-II 700 NMR spectrometer equipped with a cryo-
genic probe. The NMR data were processed using TopSpin version
3.1 and analyzed using CARA. 15N-labeled SH protein (0.6 mM) was
reconstituted in 100 mM acetate buffer at pH 4.4 and 200 mM
DPC. The titration experiments with BAP31 endodomain were
performed with 15N-labeled SH protein in DPC micelles from SH
protein/BAP31 endodomain molar ratio 1:0.5 to 1:2. Chemical shift
perturbation (CSP) values were calculated using the formula
CSP¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ΔδH2þð0:23 ΔδNÞ2
q
.
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